Quarantined research extract
Bulk identifiable extract hits DLP; privacy analyst human-reviews purpose and protocol before release.
Human Reviews
Medium Risk
Moderate
Low Cost
AC-4(9) requires human reviews as an enhancement to base AC-4 information flow enforcement. Base AC-4 establishes that flows must be authorized; this enhancement adds: Require human review before releasing ambiguous or high-risk ePHI flows (bulk research extracts, media disclosures, unusual HIE payloads). Healthcare delivery organizations rely on this to keep ePHI within approved clinical, billing, and research pathways.
Control Objective
Organize human reviews for filtered or quarantined information flows before ePHI leaves or enters designated environments.
Implementation Guidance
- Define which quarantines require human review.
- Staff privacy/HIM reviewers with after-hours coverage.
- Capture reviewer rationale and decision in tickets.
- Set SLAs so care-related disclosures are timely.
- Sample reviewer decisions for quality.
- Escalate unclear legal basis to privacy officer.
- Keep audit trail of release after review.
- Tabletop a surge of quarantines.
Real-World Use Cases
How this control shows up in healthcare and HIPAA-covered environments.
Ambiguous media disclosure
HIM requests burn of imaging for patient pickup; reviewer confirms identity and contents before approving the flow.
Unusual HIE payload
Interface flags an unexpectedly large CCD; on-call privacy reviews before the partner receives it.
Best Practices
- Tie AC-4(9) to named owners in IAM/privacy/security.
- Prefer system enforcement over informal email approval.
- Measure coverage on systems that store or transmit ePHI.
- Review exceptions at least quarterly.
- Correlate events into SIEM use cases.
- Document mapping to HIPAA safeguards in the SSP.
Common Gaps & Violations
- Policy claims human reviews but no technical enforcement on EHR paths.
- Exceptions granted permanently without review.
- Vendors and research feeds left out of scope.
- Logs not retained or not reviewed.
- Upgrades silently disable the control.
Required Documentation
- Policy/procedure for Human Reviews (AC-4(9))
- Configuration baselines and diagrams
- Exception register
- Sample logs/alerts
- Training or runbook evidence
How to Test & Validate
- Attempt a prohibited action related to human reviews; confirm block or required workflow.
- Complete an authorized path; confirm success and logging.
- Sample exceptions for expiry and approval.
- Verify ePHI systems in scope are covered (not only corporate IT).
- Confirm SIEM/alert or retention evidence for the last 90 days.
Audit Considerations
Assessors look for operating evidence of Human Reviews on systems touching ePHI — screenshots, logs, and failed-test results — not only a policy paragraph referencing AC-4(9).
HIPAA Mapping
How this NIST control supports HIPAA Security Rule expectations.
- 164.312(a)(1) Access Control — limit system access and, by extension, unauthorized information movement.
- 164.312(e)(1) Transmission Security — guard ePHI transmitted over networks and interconnections.
- 164.308(a)(4) Information Access Management — policies for access and disclosure pathways.
- 164.530(c) Safeguards / 164.514 Minimum Necessary — reduce unnecessary data in flows.
Compliance Tips
- List AC-4(9) explicitly in the system security plan control matrix.
- Prioritize EHR, VPN, HIE, and BA file-transfer paths.
- Keep a one-page evidence pack (config + sample log + exception list) ready for assessors.
Frequently Asked Questions
Does every transfer need a human?
No — reserve human review for quarantines, high-risk, or ambiguous cases defined by policy.
How fast must review be?
Define SLAs so clinical care disclosures are not stuck; staff after-hours coverage.
Can review be rubber-stamped?
Require rationale and sampling of reviewer decisions.
References & Resources
- NIST SP 800-53 Rev. 5 — AC-4(9)
- Related controls: AC-4, AC-4(8), AU-6
Related Guidelines
Related controls that commonly accompany AC-4(9).
Need Help Implementing AC-4(9)?
Our auditors map NIST SP 800-53 controls to your HIPAA Security Rule program — policies, technical evidence, and audit readiness.